Abstract
The atopic diseases include atopic eczema, allergic rhinitis and asthma. The prevalence of atopic diseases has been on the rise for several decades, particularly in high-income industrialized nations (ISAAC, 1998; Sibbald et al., 1990). As potential explanations for the increased prevalence of atopic diseases the so-called hygiene hypothesis has been suggested. The hypothesis suggests that the continuously increased hygiene in the environment and the food supply results to reduced exposure to a variety of microbes and consequently to a less diverse intestinal microbiota from early life onwards and/or to changes in the gut microbiota from early life. Such changes reflect the exposure to microbes in industrially processed foods and the improved hygiene of the living environment of the mother and infant.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrahamsson TR, Jakobsson T, Bottcher MF et al. (2007) Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 119:1174–1180
Apter AJ (2003) Early exposure to allergen: is this the cat's meow, or are we barking up the wrong tree? J Allergy Clin Immunol 111:938–946
von Berg A, Filipiak-Pittroff B, Krämer U et al. (2008) Preventive effect of hydrolyzed infant formulas persists until age 6 years: long-term results from the German Infant Nutritional Intervention Study (GINI). J Allergy Clin Immunol 121:1442–1447
Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M (2001) Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108:516–520
Bos JD, Kapsenberg ML, Sillevis Smitt JH (1994) Pathogenesis of atopic eczema. Lancet 343:1338–1341
Brouwer ML, Wolt-Plompen SA, Dubois AE et al. (2006) No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36:899–906
Favier C, Vaughan E, de Vos W, Akkermans A (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl Environm Microbiol 68:219–226
Fölster-Holst R, Müller F, Schnopp N et al. (2006) Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 155:1256–1261
Fukaura H, Kent SC, Pietrusewitz MJ (1996) Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-b1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70–77
Gore C, Munro K, Lay C, Bibiloni R et al. (2008) Bifidobacterium pseudocatenulatum is associated with atopic eczema: a nested case-control study investigating the fecal microbiota of infants. J Allergy Clin Immunol 121:135–140
Grönlund MM, Arvilommi H, Kero P (2000) Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child 83:F186–192
Grönlund MM, Gueimonde M, Laitinen K et al. (2008) Maternal breast-milk and intestinal bifidobacteria guide the compositional development of the Bifidobacterium microbiota in infants at risk of allergic disease. Clin Exp Allergy 2007 Oct 18
Gueimonde M, Laitinen K, Salminen S, Isolauri E (2007) Breast milk: a source of bifidobacteria for infant gut development and maturation? Neonatology 92:64–66
Gueimonde M, Kalliomaki M, Isolauri E, Salminen S (2006) Probiotic intervention in neonates--will permanent colonization ensue? J Pediatr Gastroenterol Nutr 42:604–606
Hanifin JM (1984) Atopic dermatitis. J Allergy Clin Immunol 73:211–222
Hanifin JM (2002) Atopiform dermatitis: do we need another confusing name for atopic dermatitis? Br J Dermatol 147:430–432
Hartmann G, Weiner GJ, Krieg AM (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci USA 96:9305–9319
Huurre A, Laitinen K, Rautava S et al. (2008) Impact of maternal atopy and probiotic supplementation during pregnancy on infant sensitization: a double-blind placebo-controlled study. Clinical and Experimental Allergy 38:1342–1348
Isolauri E, Arvola T, Sütas Y (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30:1605–1610
Isolauri E, Huurre A, Salminen S, Impivaara O (2004) The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 34:1007–1010
Isolauri E, Rautava S, Kalliomäki M, Kirjavainen P, Salminen S (2002) Probiotic research: learn from the evidence. Curr Opin Immunol Clin Allergol 2:263–271
Isolauri E, Salminen S (2008) Probiotics. In Walker's Pediatric Gastrointestinal Diesease BC Dekker Inc, USA
Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73:1142S–1146S
Johansson S, Hourihane J, Bousquet J (2001) A revised nomenclature for allergy. Allergy 56:813–824
Jones CA, Holloway JA, Popplewell EJ (2002) Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 109:858–866
Juntunen M, Kirjavainen P, Ouwehand AC et al. (2003) Gut microflora changes and probiotics in children in day care centers. Bioscience and Microflora 22:155–157
Kalliomäki M, Collado MC, Salminen S, Isolauri E (2008) Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr 87:534–538
Kalliomäki M, Kirjavainen P, Eerola E et al. (2001a) Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129–134
Kalliomäki M, Ouwehand A, Arvilommi H (1999) Transforming growth factor-beta in breast milk: a potential regulator of atopic disease at an early age. J Allergy Clin Immunol 104:1251–1257
Kalliomäki M, Salminen S, Kero P et al. (2001b) Probiotics in the primary prevention of atopic disease: a randomised, placebo-controlled trial. Lancet 357:1076–1079
Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869–1871
Kalliomäki M, Salminen S, Poussa T, Isolauri E (2007) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. J Allergy Clin Immunol 119:1019–1021
Kirjavainen PV, Salminen SJ, Isolauri E (2003) Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 36:223–227
Kopp M, Hennemuth I, Heinzmann et al. (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121;e850–e856
Kukkonen K, Savilahti E, Haahtela T et al. (2008) Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 119:192–198
Kulig M, Bergmann R, Klettke U, Wahn V, Tacke U, Wahn U (1999) Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 103:1173–1179
Kulig M, Tacke U, Forster J et al. (1999) Serum IgE levels during the first 6 years of life. J Pediatr 134:453–458
Lau S, Illi S, Sommerfeld C (2000) Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Lancet 356:1392–1397
Leung DYM, Bieber T (2003) Atopic dermatitis. Lancet 361:151–160
Majamaa H, Isolauri E (1997) Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179–186
Martín R, Langa S, Reviriego C et al. (2003) Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 143:754–758
Nakagawa T, Nakagomi T, Hisamatsu S, Itaya H, Nakagomi O, Mizushima Y (1996) J Allergy Clin Immunol 97:1165–1166
Neish AS, Gewirtz AT, Zeng H (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289:1560–1563
Novak N, Bieber T, Leung DYM (2003) Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. J Allergy Clin Immunol 112:S128–139
Novak N, Bieber T, Leung DY (2003) Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 112:252–262
Penders J, Stobberingh EE, Thijs C et al. (2006) Molecular fingerprinting of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin Exp Allergy 36:1602–1608
Pepys J (1994) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Allergy 49:397–399
Repa A, Kozakova H, Hudcovic T et al. (2008) Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol Lett 117:50–56
Rautava S, Kalliomäki M, Isolauri E (2002) Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease inthe infant. J Allergy Clin Immunol 109:119–121
Rinne M, Gueimonde M, Kalliomäki M, Hoppu U, Salminen S, Isolauri E (2005) Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol Med Microbiol 43:59–65
Riedler J, Braun-Fahrländer C, Eder W (2001) Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet 358:1129–1133
Rosenfeldt V, Benfeldt E, Dam Nielsen S (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111:389 –395
Salminen S, Bouley C, Boutron-Ruault MC (1998) Gastrointestinal physiology and function - targets for functional food development. Br J Nutr 80(suppl):147–171
Salminen S, Gueimonde M (2005) Gut Microbiota in Infants between 6 and 24 Months of Age. Nestle Nutr Workshop Ser Pediatr Program 56:43–56
Salminen S, Isolauri E (2006) Probiotics, gut inflammation and barrier function. Pediatr 149:S115–120
Satokari R, Grönroos T, Laitinen K et al. (2009) Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 48:8–12
Sibbald B, Rink E, D'Souza M (1990) Is the prevalence of atopy increasing? Br J Gen Practice 40:338–340
Sistek D, Kelly R, Wickens K, Stanley T et al. (2006) Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 36:629–633
Strachan DP (1989) Hay fever, hygiene, and household size. BMJ 299:1259–1260
Sudo N, Sawamura S, Tanaka K (1997) The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 159:1739–1745
Taylor A, Hale J, Wiltschut J et al. (2006) Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clinical and Experimental Allergy 36:1227–1235
Taylor AL, Dunstan JA, Prescott SL (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119:184–191
Vicini J, Etherton T, Kris-Etherton P et al. (2008) Survey of retail milk composition as affected by label claims regarding farm-management practices. J Am Diet Ass 108:1198–1203
Viljanen M, Savilahti E, Haahtela T et al. (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60:494–500
Wen L, Ley RE, Volchkov PY et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455:1109–1113
Weston S, Halbert A, Richmond P, Prescott SL (2005) Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90:892–897
Wickens K, Black PN, Stanley TV et al. (2008) A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 122:788–794
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this entry
Cite this entry
Salminen, S., Isolauri, E. (2009). Probiotics and Allergy. In: Charalampopoulos, D., Rastall, R.A. (eds) Prebiotics and Probiotics Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79058-9_25
Download citation
DOI: https://doi.org/10.1007/978-0-387-79058-9_25
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-79057-2
Online ISBN: 978-0-387-79058-9
eBook Packages: Chemistry and Materials ScienceReference Module Physical and Materials ScienceReference Module Chemistry, Materials and Physics